Disciplina Capital Management’s Novo Nordisk NVO Stock Holding History

Disciplina Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.2K	Sell	317 -99	-24%	-$4.25K	﹤0.01%	62
2026 Q1	$15.3K	Hold	416	–	–	﹤0.01%	62
2025 Q4	$21.2K	Hold	416	–	–	﹤0.01%	62
2025 Q3	$23.1K	Hold	416	–	–	﹤0.01%	56
2025 Q2	$28.7K	Sell	416 -64	-13%	-$4.35K	﹤0.01%	56
2025 Q1	$33.3K	Buy	480 +297	+162%	+$24.5K	﹤0.01%	55
2024 Q4	$15.7K	Hold	183	–	–	﹤0.01%	58
2024 Q3	$21.8K	Buy	+183	New	+$24.4K	﹤0.01%	56

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Disciplina Capital Management's NVO Position: Q2 2026 in Review

Disciplina Capital Management reduced its Novo Nordisk (NVO) stake by 24% in Q2 2026, selling an estimated $4.25K and leaving 317 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #62.

Disciplina Capital Management first reported a position in NVO in Q3 2024 and has held it in 8 quarters since. The position peaked at $33.3K in Q1 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Disciplina Capital Management held 317 shares of Novo Nordisk worth $15.2K as of Q2 2026.
Disciplina Capital Management sold 99 Novo Nordisk shares in Q2 2026, an estimated $4.25K.
Novo Nordisk made up ﹤0.01% of Disciplina Capital Management's portfolio in Q2 2026, its #62 holding.
Disciplina Capital Management first reported a position in Novo Nordisk in Q3 2024 and has held it in 8 quarters since.
Disciplina Capital Management's Novo Nordisk position peaked at $33.3K in Q1 2025.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Disciplina Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.